Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Madeleine L Drent

Showing results (1-10 of 88) with videos related to

Pageof 9
Sort By:
European Journal of Endocrinology|September 13, 2008
Cognition in the adult with childhood-onset GH deficiencyI Caroline van Nieuwpoort, Madeleine L Drent
European Journal of Endocrinology|January 10, 2009
Quality of life is reduced in patients with Klinefelter syndrome on androgen replacement therapyWillem de Ronde, Anne de Haan, Madeleine L Drent
ISRN Endocrinology|February 25, 2012
The GH/IGF-I Axis and Cognitive Changes across a 4-Year Period in Healthy AdultsJan Berend Deijen, Lucia I Arwert, Madeleine L Drent
Advances in Clinical Chemistry|April 16, 2018
Adiponectin and Its Isoforms in PathophysiologyMerel van Andel, Annemieke C Heijboer, Madeleine L Drent
Health and Quality of Life Outcomes|July 8, 2018
Effect of low-normal and high-normal IGF-1 levels on memory and wellbeing during growth hormone replacement therapy: a randomized clinical trial in adult growth hormone deficiencyChrista C van Bunderen, Jan Berend Deijen, Madeleine L Drent
Hormones and Behavior|February 15, 2005
Long-term growth hormone treatment preserves GH-induced memory and mood improvements: a 10-year follow-up study in GH-deficient adult menLucia I Arwert, Jan Berend Deijen, Maartje Müller, et al.
Health and Quality of Life Outcomes|October 21, 2005
Differential effect sizes of growth hormone replacement on Quality of Life, well-being and health status in growth hormone deficient patients: a meta-analysisJan Berend Deijen, Lucia I Arwert, Joost Witlox, et al.
Psychoneuroendocrinology|March 15, 2016
Plasma insulin-like growth factor I levels are higher in depressive and anxiety disorders, but lower in antidepressant medication usersMariska Bot, Yuri Milaneschi, Brenda W J H Penninx, et al.
European Journal of Internal Medicine|April 28, 2016
Comparison of low-normal and high-normal IGF-1 target levels during growth hormone replacement therapy: A randomized clinical trial in adult growth hormone deficiencyChrista C van Bunderen, Paul Lips, Mark H Kramer, et al.
Psychopharmacology|April 14, 2007
Effects of the noradrenergic agonist clonidine on temporal and spatial attentionSander Nieuwenhuis, I Caroline van Nieuwpoort, Dick J Veltman, et al.
Pageof 9

Showing results (1-10 of 88) with videos related to

Sort By:
Pageof 9
European Journal of Endocrinology|September 13, 2008
Cognition in the adult with childhood-onset GH deficiencyI Caroline van Nieuwpoort, Madeleine L Drent
European Journal of Endocrinology|January 10, 2009
Quality of life is reduced in patients with Klinefelter syndrome on androgen replacement therapyWillem de Ronde, Anne de Haan, Madeleine L Drent
ISRN Endocrinology|February 25, 2012
The GH/IGF-I Axis and Cognitive Changes across a 4-Year Period in Healthy AdultsJan Berend Deijen, Lucia I Arwert, Madeleine L Drent
Advances in Clinical Chemistry|April 16, 2018
Adiponectin and Its Isoforms in PathophysiologyMerel van Andel, Annemieke C Heijboer, Madeleine L Drent
Health and Quality of Life Outcomes|July 8, 2018
Effect of low-normal and high-normal IGF-1 levels on memory and wellbeing during growth hormone replacement therapy: a randomized clinical trial in adult growth hormone deficiencyChrista C van Bunderen, Jan Berend Deijen, Madeleine L Drent
Hormones and Behavior|February 15, 2005
Long-term growth hormone treatment preserves GH-induced memory and mood improvements: a 10-year follow-up study in GH-deficient adult menLucia I Arwert, Jan Berend Deijen, Maartje Müller, et al.
Health and Quality of Life Outcomes|October 21, 2005
Differential effect sizes of growth hormone replacement on Quality of Life, well-being and health status in growth hormone deficient patients: a meta-analysisJan Berend Deijen, Lucia I Arwert, Joost Witlox, et al.
Psychoneuroendocrinology|March 15, 2016
Plasma insulin-like growth factor I levels are higher in depressive and anxiety disorders, but lower in antidepressant medication usersMariska Bot, Yuri Milaneschi, Brenda W J H Penninx, et al.
European Journal of Internal Medicine|April 28, 2016
Comparison of low-normal and high-normal IGF-1 target levels during growth hormone replacement therapy: A randomized clinical trial in adult growth hormone deficiencyChrista C van Bunderen, Paul Lips, Mark H Kramer, et al.
Psychopharmacology|April 14, 2007
Effects of the noradrenergic agonist clonidine on temporal and spatial attentionSander Nieuwenhuis, I Caroline van Nieuwpoort, Dick J Veltman, et al.
Pageof 9